Barbara Bogner

Barbara Bogner is a Researcher in the Department of Ophthalmology at the Salk Institute for Biological Studies, contributing to the Research Program of Experimental Ophthalmology and Glaucoma Research. Her work focuses on neuroprotection strategies for retinal ganglion cells (RGCs), circadian rhythms in ocular tissues, and molecular mechanisms of glaucoma.

• Role: Research Associate
• Department: Ophthalmology
• Research Affiliation: Experimental Ophthalmology and Glaucoma Research Program

Her research integrates molecular biology, neuroscience, and clinical chemistry to address ocular diseases. Key areas include gene therapy using adeno-associated virus (AAV) vectors, autonomic regulation of choroidal growth factors, and circadian clock localization in eye tissues.

Scientific Awards:

• ARVO Travel Grant (2012)
• ÖOG Drobec Poster Preis (2010)
• ÖOG-EVER Travel Grant (2009)

Bogner has served as principal investigator (PI) in projects studying vasopressin receptors in the rabbit eye, AAV-based gene transfer in ocular tissues, and blood flow measurement methods. Her publications span neuroprotection, molecular therapy, and clinical biomarker analysis.